Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

10,506articles mentioning drugs

58,393drug mentions

9,496distinct drugs extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

View all 9,496 drugs on one page

Articles mentioning drugs

10,506 articles · page 323 of 876

E-129 Effectiveness of continuous intra-arterial nimodipine infusion for the treatment of refractory vasospasm after aneurysmal subarachnoid hemorrhage

neurintsurg · abstract · 2026-07-19 · 4 matching annotations

98.4%

nimodipine heparin heparin-induced aneurysmal subarachnoid hemorrhage aneurysmal SAH Angiographic Vasospasm

…he procedure is temporary maintained. Continuous intra-arterial nimodipine infusion (CIN) can be considered for severe diffuse vasospasm w…

E-199 Twist-drill craniostomy with subdural drain placement and middle meningeal artery embolization for chronic subdural hematoma: clinical and volumetric analysis of a minimally invasive management strategy

neurintsurg · abstract · 2026-07-19 · 4 matching annotations

91.4%

Markwalder antithrombotic agents chronic subdural hematoma (cSDH)cSDH FDA

…d midline shift (68% and 83%). At 1 month, 88% of patients were Markwalder grade 0 and 12% grade 1. One hematoma (1.6%) required repeat in…

E-252 Periprocedural cangrelor in intracranial aneurysm treatment: a systematic review and meta-analysis

neurintsurg · abstract · 2026-07-19 · 4 matching annotations

98.3%

Cangrelor Intracranial aneurysms PubMed Embase Cochrane Library subarachnoid hemorrhage

…s due to their slow onset of action and inconsistent responses. Cangrelor, an intravenous P2Y12 inhibitor with rapid action, may provide …

E-283 Adjunctive middle meningeal artery embolization reduces recurrence following seps evacuation of chronic subdural hematoma: a systematic review

neurintsurg · abstract · 2026-07-19 · 4 matching annotations

83.5%

anticoagulants antiplatelet agents cSDH chronic subdural hematomas (cSDH)SEPS Medtronic MMAE Middle meningeal artery embolization

…prised 30.9% and 34.2% of each cohort, respectively. The use of anticoagulants and/or antiplatelet agents was more common in the SEPS+MMAE coh…

E-296 Association of prehospital statin exposure with mortality and in-hospital complications after subarachnoid hemorrhage

neurintsurg · abstract · 2026-07-19 · 4 matching annotations

86.9%

statins statin Aneurysmal subarachnoid hemorrhage SAH

…tions. Anti-inflammatory and endothelial stabilizing actions of statins have resulted in attention for use in SAH. Statin use may cause…

E-335 Hematogenous seeding and hardware-associated ESBL E. Coli ventriculitis: a fatal neurocritical case in the era of multidrug resistance

neurintsurg · abstract · 2026-07-19 · 4 matching annotations

92.9%

ceftazidime-avibactam ertapenem aztreonam penicillins metastatic pancreatic carcinoma ventriculitis subarachnoid hemorrhage pulmonary embolism ESBL meningitis embolized cerebellar AVM

…n. Antimicrobial therapy was transitioned to a 14-day course of ceftazidime-avibactam in coordination with infectious disease and neurosurgery. Despi…

E-340 Diagnosis and curative endovascular treatment of intrahepatic venous malformations (‘Liver Hemangiomas’)

neurintsurg · abstract · 2026-07-19 · 4 matching annotations

94.0%

Flagyl Levoquin liver hemangioma ethanol endovascular therapy

…natomic areas. We recommend covering patients with antibiotics (Flagyl and Levoquin, unless allergic) due to the potential of bacteria…

O-004 Final results of the DISTALS (distal ischemic stroke treatment with adjustable low-profile stentriever) randomized trial of tigertriever 13-EVT for DMVO

neurintsurg · abstract · 2026-07-19 · 4 matching annotations

96.5%

Tigertriever-13 ISC SNIS-2026 DMVO ESOC EQ-5D sICH FDA IV thrombolysis

… 0% (p=1), ITT, with 0 sICH in randomized patients treated with Tigertriever-13. The last patient 3-month follow-up will be completed in March …

O-009 Pressure comparisons at the clot-catheter interface of tenzing-assisted aspiration thrombectomy using a comprehensive benchtop 3D-printed circle of willis model

neurintsurg · abstract · 2026-07-19 · 4 matching annotations

84.7%

Tenzing acute ischemic stroke Route 92 Medical Aspiration thrombectomy

… correlated with clot engagement and ingestion outcomes.Results Tenzing DC withdrawal produced a brief but substantial negative pressur…

O-038 Personalized therapeutic strategies for brain arteriovenous malformations: initial results from integrated single-cell multi-omics and AI-driven hemodynamic modeling

neurintsurg · abstract · 2026-07-19 · 4 matching annotations

98.9%

trametinib sotorasib hemorrhagic stroke Brain arteriovenous malformations (bAVMs)

…lls demonstrated significant ERK phosphorylation reduction with trametinib (IC 50=12.3 nM) and sotorasib (IC50=38.7 nM).Conclusions This s…

O-041 The role of neutrophil extracellular traps (NETs) and inflammatory biomarkers in acute ischemic stroke severity and functional outcomes

neurintsurg · abstract · 2026-07-19 · 4 matching annotations

90.5%

Calprotectin stroke thrombolytics

…monstrate trends toward elevation compared to healthy controls. Calprotectin, a marker of neutrophil activation, is associated with worse fu…

O-068 First clinical experience with the surpass elite flow diverter in the treatment of intracranial aneurysms: a multicenter series

neurintsurg · abstract · 2026-07-19 · 4 matching annotations

93.5%

Surpass Elite aneurysms FDA In-Stent Stenosis

…sis of 81 consecutive aneurysms in 78 patients treated with the Surpass Elite across four centers by two experienced neurointerventionalists,…